August 1, 2012
Congratulations to Professors Andy Phillips and Alanna Schepartz, who were just awarded $2.5 million from the National Cancer Institute to investigate novel approaches to treat cancers previously considered “undruggable”. The highly competitive grant, to be distributed over five years at about $500,000 annually, comes through NCI’s “Provocative Questions” program. Schepartz and Phillips, in collaboration with Dylan Taatjes at the University of Colorado, seek to address question 18: Are there new technologies to inhibit traditionally ‘undruggable’ target molecules, such as transcription factors, that are required for the oncogenic phenotype?